Drug Shortage Report for MYLAN-ATOVAQUONE/PROGUANIL
Report ID | 189338 |
Drug Identification Number | 02402165 |
Brand name | MYLAN-ATOVAQUONE/PROGUANIL |
Common or Proper name | ATOVAQUONE/PROGUANIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | PROGUANIL HYDROCHLORIDE ATOVAQUONE |
Strength(s) | 100MG 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | P01BB |
ATC description | ANTIMALARIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-06-07 |
Actual start date | 2023-06-05 |
Estimated end date | 2023-08-17 |
Actual end date | 2023-08-18 |
Shortage status | Resolved |
Updated date | 2023-08-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v19 | 2023-08-21 | French | Compare |
v18 | 2023-08-21 | English | Compare |
v17 | 2023-08-16 | French | Compare |
v16 | 2023-08-16 | English | Compare |
v15 | 2023-07-08 | French | Compare |
v14 | 2023-07-08 | English | Compare |
v13 | 2023-06-21 | French | Compare |
v12 | 2023-06-21 | English | Compare |
v11 | 2023-06-13 | French | Compare |
v10 | 2023-06-13 | English | Compare |
v9 | 2023-06-08 | English | Compare |
v8 | 2023-05-08 | French | Compare |
v7 | 2023-05-08 | English | Compare |
v6 | 2023-05-01 | French | Compare |
v5 | 2023-05-01 | English | Compare |
v4 | 2023-04-20 | French | Compare |
v3 | 2023-04-20 | English | Compare |
v2 | 2023-04-12 | French | Compare |
v1 | 2023-04-12 | English | Compare |
Showing 1 to 19 of 19